Cross-Sector entity
All 1 tracked stories fall under one category: earnings. GLP-1 Medications is most often covered alongside Blue Buffalo, which appears in 1 of these 1 story. The tracked stories average 1 original source each. GLP-1 Medications appears in 1 tracked Cross-Sector story from February 19, 2026.
1 verified story tracked
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. GLP-1 Medications is most often covered alongside Blue Buffalo, which appears in 1 of these 1 story. The tracked stories average 1 original source each. GLP-1 Medications appears in 1 tracked Cross-Sector story from February 19, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GLP-1 Medications. Shared-story counts are live from our verified record — not editorial picks.
General Mills shares tumbled after the company lowered its full-year financial guidance, citing persistent volume pressures and shifting dietary habits. The food giant is aggressively retooling its portfolio to appeal to health-conscious consumers and those utilizing GLP-1 weight-loss medications.
Source: The Wall Street Journal
